User profiles for Anna M. Wu
Anna M. WuProfessor and Chair, Immunology & Theranostics, City of Hope Verified email at coh.org Cited by 28426 |
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu, PD Senter - Nature biotechnology, 2005 - nature.com
Immunoconjugates—monoclonal antibodies (mAbs) coupled to highly toxic agents,
including radioisotopes and toxic drugs (ineffective when administered systemically alone)—are …
including radioisotopes and toxic drugs (ineffective when administered systemically alone)—are …
Minibody: A Novel Engineered Anti-Carcinoembryonic Antigen Antibody Fragment (Single-Chain Fv-CH3) Which Exhibits Rapid, High-Level Targeting of Xenografts
…, LE Williams, JYC Wong, JE Shively, AM Wu - Cancer research, 1996 - AACR
A novel engineered antibody fragment (V L -V H -C H 3, or “minibody”) with bivalent binding
to carcinoembryonic antigen (CEA) was produced by genetic fusion of a T84.66 (anti-CEA) …
to carcinoembryonic antigen (CEA) was produced by genetic fusion of a T84.66 (anti-CEA) …
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice
This study evaluates the influence of particle size, PEGylation, and surface coating on the
quantitative biodistribution of near‐infrared‐emitting quantum dots (QDs) in mice. Polymer‐ or …
quantitative biodistribution of near‐infrared‐emitting quantum dots (QDs) in mice. Polymer‐ or …
Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output
AM Loening, TD Fenn, AM Wu… - … , Design and Selection, 2006 - academic.oup.com
Luciferases, which have seen expansive employment as reporter genes in biological
research, could also be used in applications where the protein itself is conjugated to ligands to …
research, could also be used in applications where the protein itself is conjugated to ligands to …
[HTML][HTML] Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
While chemotherapy delivery by nanocarriers has modestly improved the survival prospects
of pancreatic ductal adenocarcinoma (PDAC), additional engagement of the immune …
of pancreatic ductal adenocarcinoma (PDAC), additional engagement of the immune …
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects
The use of R. reniformis luciferase (RLuc) as a reporter gene in small-animal imaging has
been hampered by its 481 nm peaked emission spectrum, as blue wavelengths are strongly …
been hampered by its 481 nm peaked emission spectrum, as blue wavelengths are strongly …
Antibody vectors for imaging
Noninvasive molecular imaging approaches include nuclear, optical, magnetic resonance
imaging, computed tomography, ultrasound, and photoacoustic imaging, which require …
imaging, computed tomography, ultrasound, and photoacoustic imaging, which require …
An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy
The rapidly advancing field of cancer immunotherapy is currently limited by the scarcity of
noninvasive and quantitative technologies capable of monitoring the presence and …
noninvasive and quantitative technologies capable of monitoring the presence and …
Solution-phase surface modification in intact poly (dimethylsiloxane) microfluidic channels
…, CC Lee, W Lu, SP Lee, JV Leyton, AM Wu… - Analytical …, 2006 - ACS Publications
An improved approach composed of an oxidation reaction in acidic H 2 O 2 solution and a
sequential silanization reaction using neat silane reagents for surface modification of poly(…
sequential silanization reaction using neat silane reagents for surface modification of poly(…
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice
Prolonged clearance kinetics have hampered the development of intact antibodies as
imaging agents, despite their ability to effectively deliver radionuclides to tumor targets in vivo. …
imaging agents, despite their ability to effectively deliver radionuclides to tumor targets in vivo. …